Dexcom faces mounting scrutiny over G7 safety concerns, FDA violations, financial practices, and growing competition from ...
Shares of medical device company DexCom (NASDAQ:DXCM) fell 7.4% in the morning session after a short-seller report from Hunterbrook Capital alleged issues with the company's G7 glucose monitoring ...